Cargando…
Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development
Glioblastoma is the most common brain malignant tumor in the adult population, and immunotherapy is playing an increasingly central role in the treatment of many cancers. Nevertheless, the search for effective immunotherapeutic approaches for glioblastoma patients continues. The goal of immunotherap...
Autores principales: | Majc, Bernarda, Novak, Metka, Kopitar-Jerala, Nataša, Jewett, Anahid, Breznik, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912469/ https://www.ncbi.nlm.nih.gov/pubmed/33572835 http://dx.doi.org/10.3390/cells10020265 |
Ejemplares similares
-
Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres
por: Breznik, Barbara, et al.
Publicado: (2022) -
OMRT-11. The effect of microenvironment on glioblastoma stem cells therapeutic resistance
por: Turnsek, Tamara Lah, et al.
Publicado: (2021) -
TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion
por: Porčnik, Andrej, et al.
Publicado: (2021) -
Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma
por: Lah, Tamara T., et al.
Publicado: (2021) -
The Cytotoxic Effects of Cannabidiol and Cannabigerol on Glioblastoma Stem Cells May Mostly Involve GPR55 and TRPV1 Signalling
por: Lah, Tamara T., et al.
Publicado: (2022)